Epigenetic markers as predictors of neurodegeneration in long COVID survivors
DOI:
https://doi.org/10.61882/jcbior.6.2.315Keywords:
Long COVID, SARS CoV 2, Epigenetic, Neurodegeneration, Biological agingAbstract
No abstract.
References
1. Farkas G, Mahdaouy ZE, Babszky G, Jokai M, Torma F, Gu Y, et al. Associations of epigenetic aging and COVID-19: A 3-year longitudinal study. Geroscience. 2025;47(3):4889-4898.
DOI: 10.1007/s11357-025-01635-4 PMID: 40210827
2. Calzari L, Dragani DF, Zanotti L, Inglese E, Danesi R, Cavagnola R, et al. Correction: Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID 19 infection: insights from a genome wide DNA methylation study. Clin Epigenetics. 2024;16(1):158.
DOI: 10.1186/s13148-024-01764-1 PMID: 39543717
3. Shekhar Patil M, Richter E, Fanning L, Hendrix J, Wyns A, Barrero Santiago L, et al. Epigenetic changes in patients with post-acute COVID-19 symptoms (PACS) and long-COVID: A systematic review. Expert Rev Mol Med. 2024;26:e29.
DOI: 10.1017/erm.2024.32 PMID: 39435694
4. Hong P, Waldenberger M, Pritsch M, Gilberg L, Brand I, Bruger J, et al. Differential DNA methylation 7 months after SARS-CoV-2 infection. Clin Epigenetics. 2025;17(1):60.
DOI: 10.1186/s13148-025-01866-4 PMID: 40251596
5. Rasmi Y, Shokati A, Hassan A, Aziz SG, Bastani S, Jalali L, et al. The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. IBRO Neurosci Rep. 2022;14:28-37.
DOI: 10.1016/j.ibneur.2022.12.002 PMID: 36590248
6. Humaira Amanullah F, Alam T, El Hajj N, Bejaoui Y. The impact of COVID-19 on "biological aging". Front Immunol. 2024;15:1399676. DOI: 10.3389/fimmu.2024.1399676
PMID: 38919619
Downloads
Published
Issue
Section
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



